Radius Health, Inc. (RDUS) financial statements (2021 and earlier)

Company profile

Business Address ATTN: CHIEF FINANCIAL OFFICER
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:16123743033247310512
Cash and cash equivalents70591192591602912
Short-term investments1823541357431477 
Other undisclosed cash, cash equivalents, and short-term investments(91)(177)177(0)(0)0 
Restricted cash and investments  00   
Receivables23174    
Inventory, net of allowances, customer advances and progress billings564   
Inventory564    
Prepaid expense12145    
Other current assets112    
Other undisclosed current assets11(177)2720
Total current assets:20327527033548010713
Noncurrent Assets
Operating lease, right-of-use asset7
Property, plant and equipment2465210
Long-term investments and receivables  177    
Long-term investments  177    
Intangible assets, net (including goodwill)778   
Intangible assets, net (excluding goodwill)778    
Other noncurrent assets1111000
Total noncurrent assets:16121925210
TOTAL ASSETS:21928746234048210813
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities59465333212223
Accounts payable6446620
Accrued liabilities53425027151822
Employee-related liabilities     21
Interest and dividends payable     0 
Debt2     13
Other undisclosed current liabilities     (2)(1)
Total current liabilities:61465333212135
Noncurrent Liabilities
Long-term debt and lease obligation5    24 
Long-term debt, excluding current maturities     24 
Operating lease, liability5
Liabilities, other than long-term debt 000   
Other liabilities 000   
Other undisclosed noncurrent liabilities196180166    
Total noncurrent liabilities:2001801660 24 
Total liabilities:26122622033214535
Stockholders' equity
Stockholders' equity attributable to parent, including:(42)6124230746163(277)
Common stock000000 
Additional paid in capital1,1941,1651,125936907408 
Accumulated other comprehensive income (loss)0(1)(0)00(0) 
Accumulated deficit(1,237)(1,104)(882)(629)(446)(344)(277)
Warrants and rights outstanding      2
Other undisclosed stockholders' equity attributable to parent      (2)
Total stockholders' equity:(42)6124230746163(277)
Other undisclosed liabilities and equity      255
TOTAL LIABILITIES AND EQUITY:21928746234048210813

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues
(Revenue, Net)
  22    
Cost of revenue
(Cost of Goods and Services Sold)
(16)(8)(0)    
Gross profit:(16)(8)22    
Operating expenses(269)(295)(270)(185)(99)(59)(67)
Other undisclosed operating income (loss)17398(1)    
Operating loss:(112)(204)(249)(185)(99)(59)(67)
Nonoperating income (expense)46321(1)9
Investment income, nonoperating46321(0)0
Other nonoperating income (expense)00(0)(0)(0)(1)9
Interest and debt expense(25)(23)(8) (3)(3)(2)
Net loss:(133)(221)(254)(183)(102)(63)(61)
Other undisclosed net income attributable to parent     00
Net loss attributable to parent:(133)(221)(254)(183)(102)(62)(61)
Preferred stock dividends and other adjustments     (9)(17)
Net loss available to common stockholders, diluted:(133)(221)(254)(183)(102)(71)(78)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(133)(221)(254)(183)(102)(63)(61)
Comprehensive loss:(133)(221)(254)(183)(102)(63)(61)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1(0)(0)0000
Comprehensive loss, net of tax, attributable to parent:(132)(222)(255)(183)(102)(63)(61)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: